ioxitalamic acid has been researched along with Ovarian Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amant, F; De Keyzer, F; Dresen, R; Fieuws, S; Leunen, K; Michielsen, KL; Moerman, P; Op de Beeck, K; Vandecaveye, V; Vanslembrouck, R; Vergote, I | 1 |
| Buy, JN; Deligne, L; Ghossain, MA; Hugol, D; Mark, AS; Poitout, P; Truc, JB; Vadrot, D | 1 |
2 other study(ies) available for ioxitalamic acid and Ovarian Neoplasms
| Article | Year |
|---|---|
Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Contrast Media; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Humans; Iothalamic Acid; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Triiodobenzoic Acids; Whole Body Imaging | 2016 |
Focal hyperdense areas in endometriomas: a characteristic finding on CT.
Topics: Carcinoma; Contrast Media; Diagnosis, Differential; Endometriosis; Female; Humans; Iothalamic Acid; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 1992 |